486 related articles for article (PubMed ID: 21712732)
1. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
[TBL] [Abstract][Full Text] [Related]
2. Hyperresistinemia is associated with postmenopausal breast cancer.
Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
Menopause; 2013 Aug; 20(8):845-51. PubMed ID: 23481121
[TBL] [Abstract][Full Text] [Related]
3. Could serum visfatin be a potential biomarker for postmenopausal breast cancer?
Dalamaga M; Archondakis S; Sotiropoulos G; Karmaniolas K; Pelekanos N; Papadavid E; Lekka A
Maturitas; 2012 Mar; 71(3):301-8. PubMed ID: 22261365
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.
Dalamaga M
Med Hypotheses; 2012 Nov; 79(5):617-21. PubMed ID: 22922056
[TBL] [Abstract][Full Text] [Related]
5. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.
Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K
Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961
[TBL] [Abstract][Full Text] [Related]
6. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients.
Hancke K; Grubeck D; Hauser N; Kreienberg R; Weiss JM
Breast Cancer Res Treat; 2010 Jan; 119(2):367-7. PubMed ID: 19842034
[TBL] [Abstract][Full Text] [Related]
7. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.
Assiri AM; Kamel HF; Hassanien MF
Dis Markers; 2015; 2015():253519. PubMed ID: 25838618
[TBL] [Abstract][Full Text] [Related]
8. Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer.
Nakajima TE; Yamada Y; Hamano T; Furuta K; Matsuda T; Fujita S; Kato K; Hamaguchi T; Shimada Y
Cancer Sci; 2010 May; 101(5):1286-91. PubMed ID: 20331631
[TBL] [Abstract][Full Text] [Related]
9. High leptin/adiponectin ratio and serum triglycerides are associated with an "at-risk" phenotype in young severely obese patients.
Labruna G; Pasanisi F; Nardelli C; Caso R; Vitale DF; Contaldo F; Sacchetti L
Obesity (Silver Spring); 2011 Jul; 19(7):1492-6. PubMed ID: 21183936
[TBL] [Abstract][Full Text] [Related]
10. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
11. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
[TBL] [Abstract][Full Text] [Related]
12. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of diagnostic and predictive value of serum adipokines: Leptin, resistin and visfatin in postmenopausal breast cancer.
Assiri AM; Kamel HF
Obes Res Clin Pract; 2016; 10(4):442-53. PubMed ID: 26388139
[TBL] [Abstract][Full Text] [Related]
14. Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome.
Kolsgaard ML; Wangensteen T; Brunborg C; Joner G; Holven KB; Halvorsen B; Aukrust P; Tonstad S
Scand J Clin Lab Invest; 2009; 69(8):858-64. PubMed ID: 19929281
[TBL] [Abstract][Full Text] [Related]
15. Visfatin in juvenile obesity - the effect of obesity intervention and sex.
Krzystek-Korpacka M; Patryn E; Bednarz-Misa I; Hotowy K; Noczynska A
Eur J Clin Invest; 2011 Dec; 41(12):1284-91. PubMed ID: 21569027
[TBL] [Abstract][Full Text] [Related]
16. Visfatin levels in prepubertal children born small or large for gestational age.
Giapros VI; Kiortsis DN; Evagelidou EN; Challa AS; Cholevas VK; Siomou EC; Bairaktari ET; Andronikou SK
Horm Metab Res; 2012 Feb; 44(2):135-9. PubMed ID: 22314334
[TBL] [Abstract][Full Text] [Related]
17. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D
Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419
[TBL] [Abstract][Full Text] [Related]
18. Leptin, adiponectin, visfatin and retinol-binding protein-4 - mediators of comorbidities in patients with psoriasis?
Gerdes S; Osadtschy S; Rostami-Yazdi M; Buhles N; Weichenthal M; Mrowietz U
Exp Dermatol; 2012 Jan; 21(1):43-7. PubMed ID: 22151390
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
20. [Association between serum leptin, adiponectin, visfatin, obesity and hypertension in female].
Xia K; Ding R; Yang Y; Wu B; Zhang Q; Hu D
Zhonghua Nei Ke Za Zhi; 2015 Sep; 54(9):768-72. PubMed ID: 26674794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
